Skip to main content

Data Deposition made easy


Bioactivity data in ChEMBL originates from two main sources: biomedical literature and  data entering ChEMBL via data deposition. Over the years, we have seen an increase in deposited data sets (as shown in the Figure above).

To make data deposition easier, we recently did some major updates to our deposition guide and supplemented it with a deposition video, and a brief checklist for depositors.

Compound structural data must be supplied to the ChEMBL team in CTAB format / as MOL file. If a whole set of structures is supplied, then an SDF file is required. There are several ways to convert a list of SMILES to SDF. One way is to use our public ChEMBL Beaker API. Its functionalities are explained in more detail here and they can be tested interactively here. Just a few lines of code are needed to convert a list of SMILES strings into SD format.

from chembl_webresource_client.utils import utils

smiles = ["CCO", "CC(=O)C1=CC=CC=C1C(=O)O", "CCN(CC)C(=O)C(C)(C)C"]
mols = [utils.smiles2ctab(smile) for smile in smiles]
sdf = ''.join(mols)
sdf

However, for data deposition to ChEMBL you need to provide an SDF file that also includes the CIDX. A CIDX is a compound identifier linked to every compound, respectively. The respective output file should look like this:

     RDKit          2D

 12 12  0  0  0  0  0  0  0  0999 V2000
    3.7500   -1.2990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7500    1.2990    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7500   -1.2990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7500   -1.2990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7500    1.2990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7500    1.2990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5000    2.5981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0000    2.5981    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7500    3.8971    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
  9  4  1  0
M  END
>  <CIDX>  (1) 
MMV161996

$$$$

Below you find a few quick ways to generate the required SDF with CIDX included. You can use the rdkit.Chem package in several ways:

from rdkit import Chem

smiles_list = ["CCO", "CC(=O)C1=CC=CC=C1C(=O)O", "CCN(CC)C(=O)C(C)(C)C"]
cidx_list = [1, 2, 3]

with Chem.SDWriter("out.sdf") as writer:
    for smiles, cidx in zip(smiles_list, cidx_list):
        mol = Chem.MolFromSmiles(smiles)
        mol.SetProp("CIDX", str(cidx))
        writer.write(mol)   

Using the rdkit.Chem.PandasTools module allows for using RDKit molecules as columns of a Pandas dataframe. In this example the input data is a excel spreadsheet, which will come in handy for data depositors:

import pandas as pd
from rdkit.Chem import PandasTools

df = pd.read_excel("CIDX_smiles.xlsx", names=["CIDX", "smiles"])
PandasTools.AddMoleculeColumnToFrame(df, "smile","Molecule") 
PandasTools.WriteSDF(df, "out.sdf", molColName='Molecule"
                     properties=list(df.columns))

Should you want to avoid code, here is an alternative solution:

The KNIME workflow reads in a Excel file containing SMILES and CIDX in two separate columns.

 

It then transforms SMILES strings into the SMILES format (Molecule Type Cast Node), removes rows with missing structure, converts SMILES into RDKit canonical SMILES (RDKit Canon Smiles Node), and finally transforms it into SD format (RDKit to Molecule) and writes out the SDF to the indicated path (SDF Writer).

Happy structure conversion!

Comments

Popular posts from this blog

Improvements in SureChEMBL's chemistry search and adoption of RDKit

    Dear SureChEMBL users, If you frequently rely on our "chemistry search" feature, today brings great news! We’ve recently implemented a major update that makes your search experience faster than ever. What's New? Last week, we upgraded our structure search engine by aligning it with the core code base used in ChEMBL . This update allows SureChEMBL to leverage our FPSim2 Python package , returning results in approximately one second. The similarity search relies on 256-bit RDKit -calculated ECFP4 fingerprints, and a single instance requires approximately 1 GB of RAM to run. SureChEMBL’s FPSim2 file is not currently available for download, but we are considering generating it periodicaly and have created it once for you to try in Google Colab ! For substructure searches, we now also use an RDKit -based solution via SubstructLibrary , which returns results several times faster than our previous implementation. Additionally, structure search results are now sorted by

Improved querying for SureChEMBL

    Dear SureChEMBL users, Earlier this year we ran a survey to identify what you, the users, would like to see next in SureChEMBL. Thank you for offering your feedback! This gave us the opportunity to have some interesting discussions both internally and externally. While we can't publicly reveal precisely our plans for the coming months (everything will be delivered at the right time), we can at least say that improving the compound structure extraction quality is a priority. Unfortunately, the change won't happen overnight as reprocessing 167 millions patents takes a while. However, the good news is that the new generation of optical chemical structure recognition shows good performance, even for patent images! We hope we can share our results with you soon. So in the meantime, what are we doing? You may have noticed a few changes on the SureChEMBL main page. No more "Beta" flag since we consider the system to be stable enough (it does not mean that you will never

ChEMBL brings drug bioactivity data to the Protein Data Bank in Europe

In the quest to develop new drugs, understanding the 3D structure of molecules is crucial. Resources like the Protein Data Bank in Europe (PDBe) and the Cambridge Structural Database (CSD) provide these 3D blueprints for many biological molecules. However, researchers also need to know how these molecules interact with their biological target – their bioactivity. ChEMBL is a treasure trove of bioactivity data for countless drug-like molecules. It tells us how strongly a molecule binds to a target, how it affects a biological process, and even how it might be metabolized. But here's the catch: while ChEMBL provides extensive information on a molecule's activity and cross references to other data sources, it doesn't always tell us if a 3D structure is available for a specific drug-target complex. This can be a roadblock for researchers who need that structural information to design effective drugs. Therefore, connecting ChEMBL data with resources like PDBe and CSD is essen

ChEMBL 34 is out!

We are delighted to announce the release of ChEMBL 34, which includes a full update to drug and clinical candidate drug data. This version of the database, prepared on 28/03/2024 contains:         2,431,025 compounds (of which 2,409,270 have mol files)         3,106,257 compound records (non-unique compounds)         20,772,701 activities         1,644,390 assays         15,598 targets         89,892 documents Data can be downloaded from the ChEMBL FTP site:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/ Please see ChEMBL_34 release notes for full details of all changes in this release:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/chembl_34_release_notes.txt New Data Sources European Medicines Agency (src_id = 66): European Medicines Agency's data correspond to EMA drugs prior to 20 January 2023 (excluding vaccines). 71 out of the 882 newly added EMA drugs are only authorised by EMA, rather than from other regulatory bodies e.g.

In search of the perfect assay description

Credit: Science biotech, CC BY-SA 4.0 Assays des cribe the experimental set-up when testing the activity of drug-like compounds against biological targets; they provide useful context for researchers interested in drug-target relationships. Ver sion 33 of ChEMBL contains 1.6 million diverse assays spanning ADMET, physicochemical, binding, functional and toxicity experiments. A set of well-defined and structured assay descriptions would be valuable for the drug discovery community, particularly for text mining and NLP projects. These would also support ChEMBL's ongoing efforts towards an  in vitro  assay classification. This Blog post will consider the features of the 'perfect' assay description and provide a guide for depositors on the submission of high quality data. ChEMBL's assays are typically structured with the overall aim, target, and method .  The ideal assay description is succinct but contains all the necessary information for easy interpretation by database u